|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-11-20
|
|
pubmed:abstractText |
To compare the efficacy and safety of two analog insulins as starting regimens in insulin-naïve Type 2 diabetes patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biphasic Insulins,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin, Isophane,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin, Long-Acting,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin Aspart,
http://linkedlifedata.com/resource/pubmed/chemical/Metformin,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonylurea Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/glargine,
http://linkedlifedata.com/resource/pubmed/chemical/glimepiride,
http://linkedlifedata.com/resource/pubmed/chemical/insulin aspart, insulin aspart...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0947-7349
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
114
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
527-32
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17115351-Aged,
pubmed-meshheading:17115351-Biphasic Insulins,
pubmed-meshheading:17115351-Blood Glucose,
pubmed-meshheading:17115351-Body Weight,
pubmed-meshheading:17115351-Diabetes Mellitus, Type 2,
pubmed-meshheading:17115351-Dose-Response Relationship, Drug,
pubmed-meshheading:17115351-Drug Administration Schedule,
pubmed-meshheading:17115351-Drug Therapy, Combination,
pubmed-meshheading:17115351-Female,
pubmed-meshheading:17115351-Hemoglobin A, Glycosylated,
pubmed-meshheading:17115351-Humans,
pubmed-meshheading:17115351-Hypoglycemia,
pubmed-meshheading:17115351-Hypoglycemic Agents,
pubmed-meshheading:17115351-Insulin,
pubmed-meshheading:17115351-Insulin, Isophane,
pubmed-meshheading:17115351-Insulin, Long-Acting,
pubmed-meshheading:17115351-Insulin Aspart,
pubmed-meshheading:17115351-Male,
pubmed-meshheading:17115351-Metformin,
pubmed-meshheading:17115351-Middle Aged,
pubmed-meshheading:17115351-Sulfonylurea Compounds,
pubmed-meshheading:17115351-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride.
|
|
pubmed:affiliation |
Philipps-Universität Marburg, Zentrum für Innere Medizin, Bereich Endokrinologie and Diabetologie, Marburg, Germany. kannp@med.uni-marburg.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
